Published Date: 30 Apr 2025
A research team at the Technical University of Munich (TUM) has developed a method to predict early-stage kidney damage caused by certain cancer treatments. The kidneys begin to shrink slightly—months before any measurable ...
Read Full News1.
The pandemic had little impact on mental health symptoms.
2.
Why alarm is easing over a rise in pancreatic cancer among the young
3.
In Resectable Lung Cancer, Perioperative Nivolumab Increases EFS.
4.
Short-course radiation matches standard therapy for endometrial cancer
5.
Increased anti-tumor response and reduced side effects from immune checkpoint inhibitors.
1.
A Comprehensive Guide to Using an ABG Calculator for Accurate Diagnosis
2.
Revolutionizing Oncology: AI in Radiology, Machine Learning in Pathology, and Deep Learning for Cancer Detection
3.
Oncology Treatment: Innovations, Education, and Clinical Practice Insights
4.
Navigating the Stages of Thyroid Cancer: A Guide for Patients
5.
ADCs and Bispecific Antibodies: Advancing the Future of Cancer Immunotherapy
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC
2.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
3.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
4.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation